cheshtasharma

About Cheshta Sharma

This author has not yet filled in any details.
So far Cheshta Sharma has created 1323 blog entries.

IPAB holds an important decision on compulsory license for cancer drug ‘Nexavar’

Compulsory license makes it compulsory for the owner of a patent to license the use of their rights against payment either set by law or determined by arbitration. A company seeking to use a patent can do so without seeking the patent holder's consent, and pays the patent holder a set fee for the [...]

By |2017-09-07T13:20:14+05:30September 8th, 2012|IP Basics|0 Comments

Compulsory license for cancer drug ‘Nexavar’

Compulsory license makes it compulsory for the owner of a patent to license the use of their rights against payment either set by law or determined by arbitration. A company seeking to use a patent can do so without seeking the patent holder's consent, and pays the patent holder a set fee for the [...]

By |2017-09-07T13:19:46+05:30September 8th, 2012|Patent|0 Comments

Plant Genome Saviour Reward

Protection of Plant Varieties and Farmers' Rights Authority (PPV&FRA) was established by the Central Government to grant exclusive rights to the breeders and farmers who have bred, evolve or developed any kind of plant variety under the Protection of Plant Varieties and Farmers' Rights Act, 2001. PPV & FRA, Ministry of Agriculture, Government of [...]

By |2017-09-07T13:19:19+05:30September 1st, 2012|IP Basics|0 Comments

IP Associate at IIPTA, Delhi Centre: Requirement

Urgently Required – IP Associate at IIPTA, Delhi Centre Designation – IP Associate Number of openings – 2 Job Description – This job involves the under mentioned roles and responsibilities: Performing trademark, copyright, patent filing. Up taking lectures for trademarks, patent, copyright etc. in various professional programs and workshops conducted at IIPTA. Content preparation [...]

By |2017-09-07T13:18:46+05:30August 3rd, 2012|IP Interview, Job Openings|0 Comments

Natco Pharma – The Patent Warrior

Hyderabad based Natco Pharma, which successfully received India’s first compulsory license for Nexavar (cancer drug) is again in news for patent dispute with Bristol-Myers Squibb (BMS). Dispute relates to generic version of Dasatinib, crucial medicine used in chronic myeloid leukemia. Natco is selling under brand name Sprycel.Natco has gone ahead and launched a generic [...]

By |2017-09-07T13:18:14+05:30August 1st, 2012|Patent, IP Basics|0 Comments

Whirlpool Corporation Patent

Whirlpool Corporation announced in a press release that the United States District Court of Delaware ruled in favor of Whirlpool, affirming and expanding a jury's unanimous March 2010 decision that certain LG refrigerators infringe Whirlpool Corporation's patented technology. In this decision, the Court affirmed the ruling from March 2010 that LG side-by-side refrigerators infringe [...]

By |2017-09-09T12:02:14+05:30July 17th, 2012|Patent|0 Comments
Go to Top